Published in Neurosci Biobehav Rev on April 08, 2008
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci (2009) 4.32
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology (2011) 1.55
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49
Ketamine disrupts θ modulation of γ in a computer model of hippocampus. J Neurosci (2011) 1.30
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl) (2011) 1.09
The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications. Transl Psychiatry (2012) 1.08
Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia. Neuroscience (2011) 1.03
Animal models of gene-environment interactions in schizophrenia. Behav Brain Res (2009) 0.98
Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits. CNS Neurosci Ther (2013) 0.98
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology (2011) 0.97
Recent insights into the mode of action of memantine and ketamine. Curr Opin Pharmacol (2014) 0.94
Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. Toxicol Sci (2012) 0.93
NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl Psychiatry (2012) 0.90
RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia. J Neurosci (2010) 0.89
SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors. J Physiol (2013) 0.88
Behavioral effects of prenatal ketamine exposure in rhesus macaques are dependent on MAOA genotype. Exp Clin Psychopharmacol (2012) 0.87
Nogo-A-deficient Transgenic Rats Show Deficits in Higher Cognitive Functions, Decreased Anxiety, and Altered Circadian Activity Patterns. Front Behav Neurosci (2014) 0.86
Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice. Int J Neuropsychopharmacol (2014) 0.85
Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations. Curr Psychiatry Rep (2013) 0.85
Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors. Behav Pharmacol (2011) 0.84
Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia. Biol Psychiatry (2015) 0.84
Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes. Neuropsychopharmacology (2015) 0.83
Neurochemical, behavioral and architectural changes after chronic inactivation of NMDA receptors in mice. Neurosci Lett (2009) 0.83
Ketamine, Propofol, and the EEG: A Neural Field Analysis of HCN1-Mediated Interactions. Front Comput Neurosci (2013) 0.83
Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities. Curr Opin Psychiatry (2016) 0.82
Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats. Mol Psychiatry (2014) 0.82
Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivo. Front Psychiatry (2013) 0.81
Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats. Psychopharmacology (Berl) (2009) 0.80
A virtual reality task based on animal research - spatial learning and memory in patients after the first episode of schizophrenia. Front Behav Neurosci (2014) 0.80
The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophr Res Treatment (2012) 0.80
Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys. Psychopharmacology (Berl) (2010) 0.79
Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats. Psychopharmacology (Berl) (2010) 0.79
Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus of subchronic MK-801 treated rats. PLoS One (2013) 0.79
Contributions of experimental psychiatry to research on the psychosis prodrome. Front Psychiatry (2013) 0.78
A common STEP in the synaptic pathology of diverse neuropsychiatric disorders. Yale J Biol Med (2012) 0.78
Sleep spindles are related to schizotypal personality traits and thalamic glutamine/glutamate in healthy subjects. Schizophr Bull (2014) 0.78
Tandospirone, a 5-HT1A partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia. Front Behav Neurosci (2014) 0.78
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256. ACS Chem Neurosci (2016) 0.77
Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models. Front Behav Neurosci (2014) 0.77
Early postnatal lesion of the medial dorsal nucleus leads to loss of dendrites and spines in adult prefrontal cortex. Dev Neurosci (2013) 0.77
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects. Br J Pharmacol (2015) 0.76
Gene expression profiling in rodent models for schizophrenia. Curr Neuropharmacol (2010) 0.76
The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801. Neurotox Res (2016) 0.76
Phencyclidine Disrupts the Auditory Steady State Response in Rats. PLoS One (2015) 0.76
Brain in flames - animal models of psychosis: utility and limitations. Neuropsychiatr Dis Treat (2015) 0.76
Effects of Ketamine on Resting-State EEG Activity and Their Relationship to Perceptual/Dissociative Symptoms in Healthy Humans. Front Pharmacol (2016) 0.75
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders. J Alzheimers Dis (2016) 0.75
Vitamin A depletion alters sensitivity of motor behavior to MK-801 in C57BL/6J mice. Behav Brain Funct (2010) 0.75
The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats. J Exp Neurosci (2015) 0.75
Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment. Sci Rep (2016) 0.75
Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours. Metab Brain Dis (2017) 0.75
Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI. Psychopharmacology (Berl) (2013) 0.75
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. NPJ Schizophr (2017) 0.75
European mental health policy: opportunities for science and innovation, challenges for implementation. Eur J Public Health (2011) 2.06
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs (2006) 1.54
ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res (2007) 1.49
Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci (2012) 1.17
Reduced subgenual cingulate volumes in mood disorders: a meta-analysis. J Psychiatry Neurosci (2008) 1.08
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry (2008) 1.07
The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett (2004) 1.03
Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations. Neuropsychobiology (2007) 1.00
Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. World J Biol Psychiatry (2011) 0.99
White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: a two-center high-risk study. J Psychiatr Res (2010) 0.99
Amygdala volumes in mood disorders--meta-analysis of magnetic resonance volumetry studies. J Affect Disord (2008) 0.99
Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J Biol Psychiatry (2011) 0.98
The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuro Endocrinol Lett (2006) 0.98
Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study. J Psychiatr Pract (2012) 0.97
Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res (2006) 0.92
Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord (2012) 0.90
The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol (2010) 0.90
EEG source analysis in obsessive-compulsive disorder. Clin Neurophysiol (2011) 0.88
Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology (2011) 0.88
Medial frontal and dorsal cortical morphometric abnormalities are related to obsessive-compulsive disorder. Neurosci Lett (2009) 0.88
Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study. Eur Arch Psychiatry Clin Neurosci (2012) 0.87
Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study. Neurochem Res (2010) 0.86
Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients. Eur Arch Psychiatry Clin Neurosci (2009) 0.86
The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav (2005) 0.86
The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett (2006) 0.84
Prospective study of hippocampal volume and function in human subjects treated with corticosteroids. Eur Psychiatry (2006) 0.83
Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. J Affect Disord (2009) 0.83
Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuro Endocrinol Lett (2006) 0.82
Genetic variation in FOXP2 alters grey matter concentrations in schizophrenia patients. Neurosci Lett (2011) 0.81
Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study. Neuro Endocrinol Lett (2006) 0.81
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology (Berl) (2012) 0.80
The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801. Neuropharmacology (2006) 0.80
Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacology (Berl) (2007) 0.80
Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats. Pharmacol Biochem Behav (2010) 0.80
Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. J Clin Psychiatry (2014) 0.80
An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Neuro Endocrinol Lett (2007) 0.80
N-Methyl-d-Aspartate Receptor - Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia. Front Behav Neurosci (2013) 0.80
Dementia in a patient with Fahr's syndrome. Neuro Endocrinol Lett (2008) 0.80
The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett (2007) 0.78
Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders? Ann Clin Psychiatry (2007) 0.78
The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study. J Psychiatr Res (2011) 0.78
Language lateralization in monozygotic twins discordant and concordant for schizophrenia. A functional MRI pilot study. Eur Psychiatry (2007) 0.78
Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett (2004) 0.78
Why negative meta-analyses may be false? Eur Neuropsychopharmacol (2013) 0.77
Antidepressant monotherapy compared with combinations of antidepressants in the treatment of resistant depressive patients: a randomized, open-label study. Int J Psychiatry Clin Pract (2012) 0.77
Relapse prevention in schizophrenia: does group family psychoeducation matter? One-year prospective follow-up field study. Int J Psychiatry Clin Pract (2006) 0.77
Higher prevalence of antibodies to Borrelia burgdorferi in psychiatric patients than in healthy subjects. Am J Psychiatry (2002) 0.76
The effects of siRNA-mediated RGS4 gene silencing on the whole genome transcription profile: implications for schizophrenia. Neuro Endocrinol Lett (2011) 0.76
18FDG PET in hallucinating and non-hallucinating patients. Neuro Endocrinol Lett (2007) 0.76
Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.76
Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients. Neuro Endocrinol Lett (2008) 0.76
The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data. Eur Arch Psychiatry Clin Neurosci (2014) 0.76
Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride. Neuro Endocrinol Lett (2005) 0.75
Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693). J Clin Psychopharmacol (2009) 0.75
[Radioiodine therapy in patients with low-thyroid cancer]. Vnitr Lek (2015) 0.75
Magnetic resonance relaxometry in monozygotic twins discordant and concordant for schizophrenia. Eur Psychiatry (2005) 0.75
Neuroinflammation and complexes of 17β-hydroxysteroid dehydrogenase type 10--amyloid β in Alzheimer's disease. Curr Alzheimer Res (2013) 0.75
The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder. J Nerv Ment Dis (2017) 0.75
Severe hypothyroidism as a complication of anticonvulsant treatment. Epilepsia (2004) 0.75
European perspectives in psychiatry: antidepressants as an example. Acta Psychiatr Scand (2008) 0.75
Laudatio: Zdenek Klein. Neuro Endocrinol Lett (2002) 0.75
Teaching critical appraisal of articles on psychopharmacology. Acad Psychiatry (2012) 0.75
[How to read critically a scientific paper]. Cas Lek Cesk (2012) 0.75
Correlation effects in R-matrix calculations of electron-F2 elastic scattering cross sections. J Chem Phys (2007) 0.75
[Mind as an immunomodulator]. Vnitr Lek (2016) 0.75
Recognition of Images Degraded by Gaussian Blur. IEEE Trans Image Process (2015) 0.75
The effect of tryptophan depletion on the action of haloperidol in MK-801-treated rats. Eur J Pharmacol (2004) 0.75
Antidepressant monotherapy and combination of antidepressants in the treatment of resistant depression in current clinical practice: A retrospective study. Int J Psychiatry Clin Pract (2010) 0.75